Johnson & Johnson (JNJ) Tops Q3 EPS by 4c; lifts guidance
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $231.29 +1.27%
Revenue Growth %: +5.1%
Financial Fact:
Restructuring expense: 62M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +5.1%
Financial Fact:
Restructuring expense: 62M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) reported Q3 EPS of $2.80, $0.04 better than the analyst estimate of $2.76. Revenue for the quarter came in at $23.99 billion versus the consensus estimate of $23.76 billion.
GUIDANCE:
Johnson & Johnson sees FY2025 EPS of $10.80-$10.90, versus the consensus of $10.85. Johnson & Johnson sees FY2025 revenue of $93.5-93.9 billion, versus the consensus of $93.46 billion.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
- Eledon Pharamceuticals (ELDN) PT Raised to $7 at Leerink
- Apollo Private Credit Fund caps redemptions at 5% - Bloomberg
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
